Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic

NCT04367545 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT04367545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04367545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic
Lead sponsor
University Hospital, Rouen
Phase
Not applicable
Overall status
Completed
Start date
April 16, 2020
Completion date
May 17, 2020
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid, rt-ddpcr multiplex